1. Agis, F., P. Schlich, J. L. Cartel, C. Guidi, and M. A. Bach. 1988. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy. Int. J. Lepr. Other Mycobact. Dis.56:527-535.
2. Brett, S. J., P. Draper, S. N. Payne, and R. J. Rees. 1983. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. Clin. Exp. Immunol.52:271-279.
3. Buhrer-Sekula, S., M. G. Cunha, N. T. Foss, L. Oskam, W. R. Faber, and P. R. Klatser. 2001. Dipstick assay to identify leprosy patients who have an increased risk of relapse. Trop. Med. Int. Health6:317-323.
4. Buhrer-Sekula, S., E. N. Sarno, L. Oskam, S. Koop, I. Wichers, J. A. Nery, L. M. Vieira, H. J. de Matos, W. R. Faber, and P. R. Klatser. 2000. Use of ML dipstick as a tool to classify leprosy patients. Int. J. Lepr. Other Mycobact. Dis.68:456-463.
5. Cartel, J. L., S. Chanteau, J. P. Boutin, R. Plichart, P. Richez, J. F. Roux, and J. H. Grosset. 1990. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands. Int. J. Lepr. Other Mycobact. Dis.58:512-517.